SciELO - Scientific Electronic Library Online

 
vol.32 issue4Multidisciplinary clinical management of complex patient with Crohn's disease and paradoxical psoriasiform reactionPharmacokinetics of dabigatran and use of its antidote idarucizumab author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista de la OFIL

On-line version ISSN 1699-714XPrint version ISSN 1131-9429

Abstract

CLARAMUNT-GARCIA, R; MUNOZ-CID, CL  and  SANCHEZ-RUIZ, A. Tumor lysis syndrome in hematologic patient. Rev. OFIL·ILAPHAR [online]. 2022, vol.32, n.4, pp.407-409.  Epub Oct 23, 2023. ISSN 1699-714X.  https://dx.doi.org/10.4321/s1699-714x20220004000017.

Tumor lysis syndrome (TLS) is a life-threatening complication characterized by a massive lysis of tumor cells. The following is the case of a 28-year-old man diagnosed with high-grade B-cell nonHodking lymphoma. The patient presented a TLS after the administration of chemotherapy. This case is of special interest due to the pharmaco logical recommendations proposed by the Pharmacy Service regarding the rasburicasa dose and the interactions at the electrolyte level with the concomitant medication prescribed during admission.

Keywords : Rasburicase; tumor lysis; lymphoma.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )